News
MyoPowers schließt Serie-B-Finanzierungsrunde von www.pharma-zeitung.de › MyoPowe...
www.pharma-zeitung.de
Der Vorstandsvorsitzende Ivan Csendes erklärte dazu: "Die Aufnahme von Truffle Capital in den Vorstand, unsere Serie-B-Investoren und die ...
Año 2012
www.plgs-spain.com
You can send your proposals either to Helga Prosenz (helga.prosenz@swissplg. ch) or to me. Thank you. Best regards, Ivan Csendes, PhD. Swiss PLG Board ...
Avicenna Oncology and the Big Challenge: The biotechnetbiotechnet.ch › files › aktuell › dateien › lsp-avicenna
biotechnet.ch
Dr Ivan Csendes to the Advisory Board of Avicenna Oncology. The long-time. Head of Laboratory in antibiotic chemis- try was President of the Swiss Pharma.
MyoPowers Closes Series B Investment of CHF 16 Million ...www.startupticker.ch › news › july › myopowers...
www.startupticker.ch
According to the Chairman of the Board, Ivan Csendes, “The addition of Truffle Capital to the board, our Series B investors and the successful ...
sorted by relevance / date